Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a life-saving treatment for respiratory failure that may serve as a bridge to patient recovery or lung transplantation. In COVID-19, recovery is somewhat unpredictable and occasionally occurs after >100 days on VV-ECMO support. Thus, determining therapy cessation may be difficult. We report the case of a 59-year-old male without specific risk factors admitted to a tertiary center for rapidly progressive respiratory failure due to severe COVID-19, despite aggressive mechanical ventilatory support. Immediate insertion of VV-ECMO was associated with prompt resolution of hypoxemia and hypercapnia; however, all therapeutic efforts to wean the patient from VV-ECMO failed. During the prolonged hospitalization on VV-ECMO, sepsis was the most life-threatening complication. The patient overcame roughly 40 superinfections, predominantly affecting the respiratory tract, and spent 183 days on antimicrobial treatment. Although the function of other organ systems was generally stable, gradually progressive right ventricular dysfunction due to precapillary pulmonary hypertension required increasing doses of inotropes. A successful lung transplantation was performed after 207 days of VV-ECMO support. The present case provides evidence for prolonged VV-ECMO therapy as a bridge to lung transplantation in severe COVID-19 despite numerous, predominantly infectious complications.

Department of Cardiology Na Homolce Hospital 15030 Prague Czech Republic

Department of Clinical Microbiology and ATB Center Na Homolce Hospital 15030 Prague Czech Republic

Prague Lung Transplant Program 3rd Department of Surgery Motol University Hospital 15006 Prague Czech Republic

Rehabilitation Center Rehabilitation Hospital of Beroun 26656 Beroun Czech Republic

Zobrazit více v PubMed

Armstrong R.A., Kane A.D., Kursumovic E., Oglesby F.C., Cook T.M. Mortality in patients admitted to intensive care with COVID-19: An updated systematic review and meta-analysis of observational studies. Anaesthesia. 2021;76:537–548. doi: 10.1111/anae.15425. PubMed DOI PMC

Menaker J., Rabinowitz R.P., Tabatabai A., Tesoriero R.B., Dolly K., Cornachione C., Edward S., Jessica B., Joseph K., Kon M.N., et al. Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: How Long Is Too Long? ASAIO J. 2019;65:192–196. doi: 10.1097/MAT.0000000000000791. PubMed DOI

Barbaro R.P., MacLaren G., Boonstra P.S., Iwashyna T.J., Slutsky A.S., Fan E., Bartlett R.H., E Tonna J., Hyslop R., Fanning J.J., et al. Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396:1071–1078. doi: 10.1016/S0140-6736(20)32008-0. PubMed DOI PMC

Broman L.M., Eksborg S., Coco V.L., De Piero M.E., Belohlavek J., Lorusso R. Extracorporeal membrane oxygenation for COVID-19 during first and second waves. Lancet Respir. Med. 2021;9:e80–e81. doi: 10.1016/S2213-2600(21)00262-9. PubMed DOI PMC

Xu Z., Xu Y., Liu D., Liu X., Zhou L., Huang Y., Li Y., Liu X. Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19. Front. Med. 2021;8:681548. doi: 10.3389/fmed.2021.681548. PubMed DOI PMC

Wiktor A.J., Haft J.W., Bartlett R.H., Park P.K., Raghavendran K., Napolitano L.M. Prolonged VV ECMO (265 Days) for ARDS without technical complications. ASAIO J. 2015;61:205–206. doi: 10.1097/MAT.0000000000000181. PubMed DOI

Umei N., Ichiba S., Sakamoto A. Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: A case report. Respir. Med. Case Rep. 2018;24:86–88. doi: 10.1016/j.rmcr.2018.04.015. PubMed DOI PMC

Cataño-Correa J.C., Cardona-Arias J.A., Porras Mancilla J.P., García M.T. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE. 2021;16:e0254671. doi: 10.1371/journal.pone.0254671. PubMed DOI PMC

Gajic-Veljanoski O., Phua C.W., Shah P.S., Cheung A.M. Effects of Long-Term Low-Molecular-Weight Heparin on Fractures and Bone Density in Non-Pregnant Adults: A Systematic Review with Meta-Analysis. J. Gen. Intern. Med. 2016;31:947–957. doi: 10.1007/s11606-016-3603-8. PubMed DOI PMC

Roach A., Chikwe J., Catarino P., Rampolla R., Noble P.W., Megna D., Chen Q., Emerson D., Egorova N., Keshavjee S., et al. Lung Transplantation for Covid-19-Related Respiratory Failure in the United States. N. Engl. J. Med. 2022;386:1187–1188. doi: 10.1056/NEJMc2117024. PubMed DOI PMC

Menon A.A., Berg D.D., Brea E.J., Deutsch A.J., Kidia K.K., Thurber E.G., Polsky S.B., Yeh T., Duskin J.A., Holliday A.M., et al. A Case of COVID-19 and Pneumocystis jirovecii Coinfection. Am. J. Respir. Crit. Care Med. 2020;202:136–138. doi: 10.1164/rccm.202003-0766LE. PubMed DOI PMC

Omoush S.A., Alzyoud J.A.M. The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review. Pathogens. 2022;11:445. doi: 10.3390/pathogens11040445. PubMed DOI PMC

Ni L., Cheng M.L., Feng Y., Zhao H., Liu J., Ye F., Ye Q., Zhu G., Li X., Wang P., et al. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients. Front. Immunol. 2021;12:603563. doi: 10.3389/fimmu.2021.603563. PubMed DOI PMC

Martucci G., Schmidt M., Agerstrand C., Tabatabai A., Tuzzolino F., Giani M., Ramanan R., Grasselli G., Schellongowski P., Riera J., et al. Transfusion practice in patients receiving VV ECMO (PROTECMO): A prospective, multicentre, observational study. Lancet Respir. Med. 2022. in press . PubMed DOI

Akkanti B., Hussain R., Nathan S., Gentry B., Young A.Y., Raissi F., Nascimbene A., Rajapreyar I.N., Banjac I.D., Patel K., et al. Prolonged Venovenous Extracorporeal Membrane Oxygenation in a Patient With Acute Respiratory Distress Syndrome. ASAIO J. 2016;62:e13–e14. doi: 10.1097/MAT.0000000000000321. PubMed DOI

Lee S.-H., Jung J.-S., Chung J.-H., Lee K.-H., Kim H.-J., Son H.-S., Sun K. Right Heart Failure during Veno-Venous Extracorporeal Membrane Oxygenation for H1N1 Induced Acute Respiratory Distress Syndrome: Case Report and Literature Review. Korean J. Thorac. Cardiovasc. Surg. 2015;48:289–293. doi: 10.5090/kjtcs.2015.48.4.289. PubMed DOI PMC